Goldman Sachs Group Inc Covetrus, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	BUY	$20.69 - $20.91 $5.71 Million - $5.77 Million	275,897 Added 18.17%	1,794,373 $37.5 Million
Q3 2022 Nov 10, 2022	BUY	$20.69 - $20.91 $5.71 Million - $5.77 Million	275,897 Added 18.17%	1,794,373 $37.5 Million
Q2 2022 May 14, 2024	BUY	$13.8 - $20.82 $21 Million - $31.6 Million	1,518,476 New	1,518,476 $31.5 Million
Q2 2022 Aug 15, 2022	BUY	$13.8 - $20.82 $10.3 Million - $15.6 Million	748,344 Added 97.17%	1,518,476 $31.5 Million
Q1 2022 May 16, 2022	SELL	$15.96 - $18.87 $5.11 Million - $6.04 Million	-320,011 Reduced 29.35%	770,132 $12.9 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $20.37 $2.76 Million - $3.34 Million	164,135 Added 17.73%	1,090,143 $21.8 Million
Q3 2021 Nov 10, 2021	BUY	$18.14 - $27.03 $16.8 Million - $25 Million	926,008 New	926,008 $16.8 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.